- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Canada
Total 82 results
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
PfizerCompletedLeukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositiveFrance, United States, Canada, Spain, Czechia, Singapore, Thailand, Denmark, Norway, Korea, Republic of, Finland, Hungary, Sweden, Netherlands, Italy, Germany, Ukraine, South Africa, Taiwan, Australia, Belgium, Israel, Mexico, Poland, S... and more
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChronic Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveUnited States, Canada, Australia, Puerto Rico
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... and other collaboratorsCompletedIDH2 Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Chronic-phase MyelofibrosisUnited States, Canada
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Blast CrisisNetherlands, United States, Italy, Austria, Canada, France, Germany, Singapore, Taiwan, United Kingdom, Australia, Korea, Republic of, Philippines, Sweden, Finland, Israel, Belgium, Denmark, Norway, Switzerland
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
University Health Network, TorontoNovartisCompletedChronic Phase Chronic Myeloid Leukemia | Philadelphia Positive Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blastic Phase Chronic Myeloid Leukemia | Resistant to Tyrosine Kinase Inhibitor TherapyCanada
-
PETHEMA FoundationCompleted
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
Versailles HospitalUniversity Hospital, Bordeaux; Maisonneuve-Rosemont HospitalCompletedChronic Myelogenous Leukemia, BCR/ABL PositiveFrance, Canada
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Bristol-Myers SquibbPPD; European Organisation for Research and Treatment of Cancer - EORTC; ICON... and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaUnited States, Canada, France, Germany, Italy, Spain
-
National Cancer Institute (NCI)Active, not recruitingChronic Myeloid Leukemia, BCR-ABL1 PositiveUnited States, Canada
-
National Cancer Institute (NCI)CompletedJuvenile Myelomonocytic Leukemia | Recurrent Disease | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Childhood Solid Neoplasm | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia... and other conditionsUnited States, Canada
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, Chronic PhaseUnited States, Argentina, Italy, Canada, Australia, Brazil
-
Novartis PharmaceuticalsNo longer availableChronic Myelogenous LeukemiaCanada
-
Novartis PharmaceuticalsCompleted
-
TakedaActive, not recruitingMyeloid Leukemia, Chronic, Chronic PhaseUnited States, Spain, Taiwan, Australia, Canada, Russian Federation, Sweden, Switzerland, Germany, United Kingdom, Poland, Korea, Republic of, Argentina, Hong Kong, Singapore, Italy, Chile, Czechia, Denmark, France, Portugal
-
Astex Pharmaceuticals, Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, AcuteUnited States, France, Canada
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)Germany, Belgium, France, Italy, Spain, Hungary, Austria, Sweden, Bulgaria, Denmark, Greece, Slovenia, United Kingdom, Czechia, Romania, Serbia, Slovakia, Portugal, Finland, Norway, Poland
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
Asan Medical CenterCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKorea, Republic of, Canada
-
Sarit AssoulineNovartisRecruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia in Remission | Chronic Myeloid Leukemia, BCR/ABL-PositiveCanada
-
Novartis PharmaceuticalsCompletedCHRONIC MYELOGENOUS LEUKEMIACanada, Australia, Spain, Argentina, France, Brazil
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaChina, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaUnited States, Canada
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
Fundacion CRIS de Investigación para Vencer el...Apices Soluciones S.L.; Incyte Biosciences UKActive, not recruitingChronic Myeloid Leukemia, Chronic PhaseSpain
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive Chronic Myelogenous LeukemiaGermany, Canada, France, Spain, Italy
-
University Health Network, TorontoUnknown
-
Brian LeberUniversity Health Network, TorontoCompletedChronic Myeloid LeukemiaCanada
-
ShireCompleted
-
University of British ColumbiaBristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaSpain, United Kingdom, Germany, Canada, Austria, France, Korea, Republic of, Greece, Singapore, Italy, Argentina, Poland, Vietnam, Malaysia, Oman, Brazil
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaUnited States, United Kingdom, Hungary, Japan, Saudi Arabia, Australia, Germany, Canada, France, Netherlands, Spain, Lebanon, Turkey, Korea, Republic of, Argentina, Brazil, Bulgaria, Czechia, Israel, Italy, Mexico, Romania, Russian... and more
-
Bristol-Myers SquibbCompletedLeukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myeloid Leukemia, Chronic, Accelerated PhaseAustralia, Canada, France, Germany, Italy, Korea, Republic of, Taiwan, Thailand, United States, Spain, Austria, Denmark, Belgium, Sweden, Switzerland, Netherlands, Peru, South Africa, Philippines, Singapore, Russian Federation, Br... and more
-
University Health Network, TorontoOzmosis Research Inc.UnknownChronic Myeloid LeukemiaCanada
-
Novartis PharmaceuticalsActive, not recruitingHematologic Diseases | Chronic Myelogenous Leukemia | CML | Leukemia, Myeloid ChronicTaiwan, Italy, Spain, United Kingdom, Germany, United States, Korea, Republic of, France, Russian Federation, Canada, Denmark, Poland, Portugal, Austria, Czechia
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaBelgium, Spain, Austria, Germany, Italy, France, Netherlands, Sweden, Japan, United States, Greece, United Kingdom, Bulgaria, Hungary, Argentina, Poland, Colombia, Ireland, Denmark
-
Novartis PharmaceuticalsRecruitingLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myelogenous LeukemiaDenmark, Spain, France, Germany, Lebanon, Italy, Argentina, Czechia, Portugal, United Kingdom, Brazil, Mexico, Russian Federation, Taiwan, Austria, Canada, Korea, Republic of, Turkey, United States, Singapore, Japan, Bulgaria, Poland, Romani... and more
-
Fundación Teófilo Hernando, SpainRecruitingChronic Myeloid LeukemiaSpain
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaCanada, Italy, United States, United Kingdom, Belgium, Germany, France, Switzerland, Austria, Denmark, Spain, Norway, Sweden, Netherlands, New Zealand, Australia
-
Novartis PharmaceuticalsCompletedMyelogenous Leukemia, ChronicSouth Africa, Italy, Belgium, Japan, Taiwan, Turkey, Canada, Germany, Spain, Egypt, United States, Singapore, Austria, France, Netherlands, Sweden, United Kingdom, Korea, Republic of, Hong Kong, Thailand, Russian Federation, Brazil, Hungar... and more
-
University of Milano BicoccaCompletedChronic Myeloid LeukemiaCanada, Germany, Israel, Italy, Spain
-
Bristol-Myers SquibbCompletedChronic Myeloid LeukemiaAustralia, Italy, Canada, United States, Germany, Spain, France
-
Kartos Therapeutics, Inc.RecruitingChronic Myeloid LeukemiaItaly, Spain, United States, Korea, Republic of, France, Poland, Canada, Russian Federation